Skip to main content

Advertisement

Log in

Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

There is limited available literature examining factors that predispose patients to the development of LMC after stereotactic radiosurgery (SRS) for brain metastases. We sought to evaluate risk factors that may predispose patients to LMC after SRS treatment in this case–control study of patients with brain metastases who underwent single-fraction SRS between 2011 and 2016. Demographic and clinical information were collected retrospectively for 19 LMC cases and 30 controls out of 413 screened patients with brain metastases. Risk factors of interest were evaluated by univariate and multivariate logistic regression analyses and overall survival rates were evaluated by Kaplan–Meier survival analysis. About 5% of patients with brain metastases treated with SRS developed LMC. Patients with LMC (median 154 days, 95% CI 33–203 days) demonstrated a poorer overall survival than matched controls (median 417 days, 95% CI 121–512 days, p = 0.002). The most common primary tumor histologies  that lead to the development of LMC were non-small cell lung cancer (36.8%), breast cancer (26.3%), and melanoma (21.1%). No association was found between the risk of LMC and the location of the brain lesion or total volume of brain metastases. Prior surgical resection of brain metastases before SRS was associated with a 6.5 times higher odds (95% CI 1.45–29.35, p = 0.01) of developing LMC post-radiosurgery compared to those with no prior resections of brain metastases. Additionally, adjuvant WBRT may help to reduce the risk of LMC and can be considered in decision-making for patients who have had brain metastasectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14(1):48–54

    Article  PubMed  Google Scholar 

  2. Delattre JY, Krol G, Thaler HT, Posner JB (1998) Distribution of brain metastases. Arch Neurol 45:741–744

    Article  Google Scholar 

  3. Van Horn A, Chamberlain MC (2012) Neoplastic meningitis. J Support Oncol 10(2):45–53

    Article  PubMed  Google Scholar 

  4. Chamberlain MC, Corey-Bloom J (1991) Leptomeningeal metastases: 111-indium-DTPA CSF flow studies. Neurology 41:1765–1769

    Article  CAS  PubMed  Google Scholar 

  5. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25(2):103–119

    Article  CAS  PubMed  Google Scholar 

  6. Chamberlain MC, Sandy AD, Press GA (1990) Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 40:435–438

    Article  CAS  PubMed  Google Scholar 

  7. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483–2491

    Article  CAS  PubMed  Google Scholar 

  8. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044

    Article  PubMed  Google Scholar 

  9. Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40(1):48–59

    Article  PubMed  Google Scholar 

  10. Hartford AC, Paravati AJ, Spire WJ et al (2013) Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size. Int J Radiat Oncol Biol Phys 3(85):650–655

    Article  Google Scholar 

  11. Ring KS, Ge B, Petroski G et al (2016) Radiosurgery to the postoperative tumor bed for metastatic carcinoma versus whole brain radiation after surgery. Cureus 8(11):e885

    Google Scholar 

  12. Sahgal A, Aoyama H, Kocher M et al (2015) Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91(4):710–717

    Article  PubMed  Google Scholar 

  13. Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745–751

    Article  CAS  PubMed  Google Scholar 

  14. Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22(6):627–635

    Article  PubMed  Google Scholar 

  15. Jung JM, Kim S, Joo J, Shin KH, Gwak HS, Lee SH (2012) Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases. J Korean Neurosurg Soc 52(3):193–199

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ojerholm E, Lee JY, Kolker J, Lustig R, Dorsey JF, Alonso-Basanta M (2014) Gamma Knife radiosurgery to four or more brain metastases in patients without prior intracranial radiation or surgery. Cancer Med 3(3):565–571

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ojerholm E, Lee JY, Thawani JP et al (2014) Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. J Neurosurg 121(Suppl):75–83

    PubMed  Google Scholar 

  18. Gans JH, Raper DM, Shah AH et al (2013) The role of radiosurgery to the tumor bed after resection of brain metastases. Neurosurgery 72(3):317–325

    Article  PubMed  Google Scholar 

  19. Iorio-morin C, Masson-côté L, Ezahr Y, Blanchard J, Ebacher A, Mathieu D (2014) Early gamma knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. J Neurosurg 121(Suppl):69–74

    PubMed  Google Scholar 

  20. van der ree TC, Dippel DW, Avezaat CJ, Sillevis smitt PA, Vecht CJ, van den Bent MJ (1999) Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatr 66(2):225–227

    Article  Google Scholar 

  21. Mahajan A, Borden J, Tsai JS (2002) Carcinomatous meningitis: are surgery or gamma knife radiosurgery treatment risk factors? J Neurosurg 97(5 Suppl):441–444

    PubMed  Google Scholar 

  22. Suki D, Hatiboglu MA, Patel AJ et al (2009) Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 64(4):664–674

    Article  PubMed  Google Scholar 

  23. Atalar B, Modlin LA, Choi CY et al (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 87(4):713–718

    Article  PubMed  Google Scholar 

  24. Johnson MD, Avkshtol V, Baschnagel AM et al (2016) Surgical resection of brain metastases and the risk of leptomeningeal recurrence in patients treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 94(3):537–543

    Article  PubMed  Google Scholar 

  25. Fortner JG (1993) Inadvertent spread of cancer at surgery. J Surg Oncol 53(3):191–196

    Article  CAS  PubMed  Google Scholar 

  26. Ahn JH, Lee SH, Kim S et al (2012) Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 116(5):984–993

    Article  PubMed  Google Scholar 

  27. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD (2006) Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 64(3):898–903

    Article  PubMed  Google Scholar 

  28. Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA (2013) Role of the blood–brain barrier in the formation of brain metastases. Int J Mol Sci 14(1):1383–1411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Tsao MN, Lloyd N, Wong RK et al (2012) Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 4:CD003869

    Google Scholar 

  30. Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82(9):1756–1763

    Article  CAS  PubMed  Google Scholar 

  31. Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87(5):694–699

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Salma K. Jabbour.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest to disclose.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, R., Levy, M., Gui, B. et al. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery. J Neurooncol 136, 395–401 (2018). https://doi.org/10.1007/s11060-017-2666-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2666-7

Keywords

Navigation